Randomized Phase I Healthy Volunteer Study of UTTR1147A (IL-22Fc): A Potential Therapy for Epithelial Injury.

Rothenberg, Michael E; Wang, Yehong; Lekkerkerker, Annemarie; Danilenko, Dimitry M; Maciuca, Romeo; Erickson, Rich; Herman, Ann; Stefanich, Eric; Lu, Timothy T

Rothenberg, Michael E; Wang, Yehong; Lekkerkerker, Annemarie; Danilenko, Dimitry M; Maciuca, Romeo; Erickson, Rich; Herman, Ann; Stefanich, Eric; Lu, Timothy T.

Affiliation

Rothenberg ME; Genentech, Inc., South San Francisco, California,, USA.
Wang Y; Genentech, Inc., South San Francisco, California,, USA.
Lekkerkerker A; Genentech, Inc., South San Francisco, California,, USA.
Danilenko DM; Genentech, Inc., South San Francisco, California,, USA.
Maciuca R; Genentech, Inc., South San Francisco, California,, USA.
Erickson R; Genentech, Inc., South San Francisco, California,, USA.
Herman A; Genentech, Inc., South San Francisco, California,, USA.
Stefanich E; Genentech, Inc., South San Francisco, California,, USA.
Lu TT; Genentech, Inc., South San Francisco, California,, USA.

Clin Pharmacol Ther ; 105(1): 177-189, 2019 01.

Article in En | MEDLINE | ID: mdl-29952004

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Recombinant Fusion Proteins / Immunoglobulin G / Interleukins / Epithelial Cells Type of study: Clinical_trials Limits: Adolescent / Adult / Female / Humans / Male / Middle aged Language: En Journal: Clin Pharmacol Ther Year: 2019 Document type: Article Affiliation country: Estados Unidos

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google